- Home
- TVTX vs ADUS Comparison
TVTX vs ADUS Comparison
Compare TVTX & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- ADUS
- Stock Information
- Founded
- TVTX 2008
- ADUS 1979
- Country
- TVTX United States
- ADUS United States
- Employees
- TVTX N/A
- ADUS N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- ADUS Medical/Nursing Services
- Sector
- TVTX Health Care
- ADUS Health Care
- Exchange
- TVTX Nasdaq
- ADUS Nasdaq
- Market Cap
- TVTX 1.7B
- ADUS 1.8B
- IPO Year
- TVTX N/A
- ADUS 2009
- Fundamental
- Price
- TVTX $20.44
- ADUS $110.70
- Analyst Decision
- TVTX Strong Buy
- ADUS Buy
- Analyst Count
- TVTX 14
- ADUS 10
- Target Price
- TVTX $33.31
- ADUS $143.50
- AVG Volume (30 Days)
- TVTX 1.6M
- ADUS 186.8K
- Earning Date
- TVTX 05-01-2025
- ADUS 05-05-2025
- Dividend Yield
- TVTX N/A
- ADUS N/A
- EPS Growth
- TVTX N/A
- ADUS 9.84
- EPS
- TVTX N/A
- ADUS 4.42
- Revenue
- TVTX $273,533,000.00
- ADUS $1,211,561,000.00
- Revenue This Year
- TVTX $68.31
- ADUS $24.03
- Revenue Next Year
- TVTX $55.65
- ADUS $5.80
- P/E Ratio
- TVTX N/A
- ADUS $25.43
- Revenue Growth
- TVTX 75.65
- ADUS 11.38
- 52 Week Low
- TVTX $6.01
- ADUS $88.96
- 52 Week High
- TVTX $25.29
- ADUS $136.72
- Technical
- Relative Strength Index (RSI)
- TVTX 61.49
- ADUS 67.83
- Support Level
- TVTX $19.84
- ADUS $103.15
- Resistance Level
- TVTX $22.07
- ADUS $101.25
- Average True Range (ATR)
- TVTX 1.11
- ADUS 3.20
- MACD
- TVTX 0.42
- ADUS 1.14
- Stochastic Oscillator
- TVTX 77.85
- ADUS 88.31
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.